(Q40904311)

24 September 2017

title

Combined use of dopamine and prostaglandin A1 in patients with acute renal failure and hepatorenal syndrome (English)

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90130-2

25 June 2022

0 references

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90130-2

25 June 2022

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90130-2

25 June 2022

author name string

F. Vincenti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A351715

25 June 2022

L. I. Goldberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A351715

25 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=351715

25 June 2022

publication date

1 March 1978

1 reference

full work available at URL

24 September 2017

https://api.elsevier.com/content/article/PII:0090698078901302?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90130-2

https://api.elsevier.com/content/article/PII:0090698078901302?httpAccept=text/plain

25 June 2022

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90130-2

25 June 2022

1 reference

24 September 2017

volume

15

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

463-472

1 reference

Hemodynamic and Renal Effects of a Prostaglandin, PGA1, in Subjects with Essential Hypertension

24 September 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90130-2

Prostaglandin A1: antihypertensive and renal effects. Studies in patients with essential hypertension

4 April 2023

4

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90130-2

Renal failure in the patient with cirrhosis. The role of active vasoconstriction.

4 April 2023

5

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90130-2

Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia

4 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90130-2

Renal and intrarenal blood-flow in cirrhosis of the liver

4 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90130-2

Effects of Intravenous Infusion of Dopamine in Cirrhotics

4 April 2023

9

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90130-2

Renal function in cirrhosis and the effects of prostaglandin A1

4 April 2023

10

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90130-2

The treatment of the hepatorenal syndrome with intra-renal administration of prostaglandin E1

4 April 2023

11

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90130-2

4 April 2023

Identifiers

1 reference

24 September 2017

1 reference